Viatris IncVTRS

時価総額

$123.9億

PER

処方薬とジェネリックを扱う医薬品の最大手。循環器から腫瘍まで複雑薬を含むポートフォリオを展開。2024年に第III相資産を350百万ドルで取得、FDAのインド工場警告が影響。米国・欧州・新興市場で展開。

	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Cash and cash equivalents	-	844	701	1,260	992	735
Accounts receivable, net	-	4,844	4,266	3,815	3,700	3,221
Inventories	-	5,472	3,978	3,520	3,470	3,854
Prepaid expenses and other current assets	-	1,707	1,958	1,811	2,028	1,711
Assets held for sale	-	-	-	230	2,786	-
Total current assets	-	12,868	10,903	10,635	12,976	9,521
Property, plant and equipment, net	-	3,460	3,189	3,025	2,760	2,666
Intangible assets, net	-	29,683	26,134	22,607	19,181	17,071
Goodwill	-	12,347	12,114	10,426	9,867	9,133
Deferred income tax benefit	-	2,148	1,333	926	693	753
Other assets	-	1,048	1,171	2,404	2,209	2,357
Total assets	-	61,553	54,843	50,022	47,686	41,501
Accounts payable	-	1,904	1,657	1,767	1,938	1,854
Income taxes payable	-	289	237	280	227	193
Long-Term Debt, Current Maturities	-	2,309	1,878	1,259	1,943	8
Liabilities held for sale	-	-	-	-	275	-
Other current liabilities	-	4,961	4,620	3,441	3,394	3,725
Total current liabilities	-	10,563	9,884	6,746	7,777	5,779
Long-term debt	-	22,429	19,717	18,015	16,188	14,039
Deferred income tax liability	-	3,124	2,815	2,432	1,736	1,108
Other long-term obligations	-	2,483	1,934	1,757	1,517	1,939
Total liabilities	-	38,599	34,350	28,950	27,218	22,865
Common Stock, Value, Issued	1	12	12	12	12	12
Additional paid-in capital	-	18,439	18,536	18,646	18,815	18,922
Retained earnings	-	5,361	3,689	5,176	4,640	3,419
Accumulated other comprehensive loss	-	-858	-1,744	-2,761	-2,747	-3,213
Stockholders Equity Parent Before Treasury Stock	-	22,954	-	-	20,719	19,140
Treasury Stock, Value	-	-	-	-	252	504
Total equity	-	22,954	20,493	21,072	20,467	18,636
Total liabilities and equity	-	61,553	54,843	50,022	47,686	41,501